Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

Benzer Materyaller

• Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
  Yazar:: Hyder, Zerin, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• brca2 and tp53 Collaborate in Tumorigenesis in Zebrafish
  Yazar:: Shive, Heather R., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
  Yazar:: Ahmed, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
  Yazar:: Smith, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?
  Yazar:: Martin, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)